TrialBMC neurology2016

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Andras Fogarasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.